Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J H Scarffe

Showing results (21-30 of 124) with videos related to

Pageof 13
Sort By:
Cancer Treatment Reports|January 1, 1983
Phase I-II evaluation of acronine in patients with multiple myelomaJ H Scarffe, A R Beaumont, D Crowther
British Journal of Hospital Medicine|April 1, 1982
Bone marrow transplantationC G Geary, D I Evans, J H Scarffe
BMJ (Clinical Research Ed.)|January 5, 2000
Lack of funding will inhibit evidence based commissioning of cancer treatmentsJ So, J H Scarffe, E Rous, et al.
Lancet (London, England)|March 5, 1977
Abnormal blood lymphocytes in non-Hodgkin's lymphomaJ V Garrett, R K Newton, J H Scarffe
Cancer Treatment Reports|January 1, 1983
Phase II trial of vindesine in advanced gastric cancerJ B Kenny, J H Scarffe, W V Maley
European Journal of Cancer & Clinical Oncology|March 1, 1983
Serum beta 2-microglobulin in patients with non-Hodgkin's lymphomaH Anderson, J H Scarffe, R Swindell, et al.
BMJ (Clinical Research Ed.)|February 12, 1999
Perspectives of commissioners and cancer specialists in prioritising new cancer drugs: impact of the evidence thresholdR Foy, J So, E Rous, et al.
British Journal of Haematology|May 1, 1979
Abnormal peripheral blood lymphocytes and bone marrow infiltration in non-Hodgkin's lymphomaJ V Garrett, J H Scarffe, R K Newton
Behring Institute Mitteilungen|August 1, 1988
Phase I study of recombinant DNA granulocyte macrophage colony stimulating factorW P Steward, J H Scarffe, R Austin, et al.
International Journal of Cell Cloning|January 1, 1990
Clinical studies with recombinant human granulocyte-macrophage colony-stimulating factorW P Steward, J H Scarffe, E Bonnem, et al.
Pageof 13

Showing results (21-30 of 124) with videos related to

Sort By:
Pageof 13
Cancer Treatment Reports|January 1, 1983
Phase I-II evaluation of acronine in patients with multiple myelomaJ H Scarffe, A R Beaumont, D Crowther
British Journal of Hospital Medicine|April 1, 1982
Bone marrow transplantationC G Geary, D I Evans, J H Scarffe
BMJ (Clinical Research Ed.)|January 5, 2000
Lack of funding will inhibit evidence based commissioning of cancer treatmentsJ So, J H Scarffe, E Rous, et al.
Lancet (London, England)|March 5, 1977
Abnormal blood lymphocytes in non-Hodgkin's lymphomaJ V Garrett, R K Newton, J H Scarffe
Cancer Treatment Reports|January 1, 1983
Phase II trial of vindesine in advanced gastric cancerJ B Kenny, J H Scarffe, W V Maley
European Journal of Cancer & Clinical Oncology|March 1, 1983
Serum beta 2-microglobulin in patients with non-Hodgkin's lymphomaH Anderson, J H Scarffe, R Swindell, et al.
BMJ (Clinical Research Ed.)|February 12, 1999
Perspectives of commissioners and cancer specialists in prioritising new cancer drugs: impact of the evidence thresholdR Foy, J So, E Rous, et al.
British Journal of Haematology|May 1, 1979
Abnormal peripheral blood lymphocytes and bone marrow infiltration in non-Hodgkin's lymphomaJ V Garrett, J H Scarffe, R K Newton
Behring Institute Mitteilungen|August 1, 1988
Phase I study of recombinant DNA granulocyte macrophage colony stimulating factorW P Steward, J H Scarffe, R Austin, et al.
International Journal of Cell Cloning|January 1, 1990
Clinical studies with recombinant human granulocyte-macrophage colony-stimulating factorW P Steward, J H Scarffe, E Bonnem, et al.
Pageof 13